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Abstract
Basal-like breast cancer (BBC) is an aggressive subtype of breast cancer that has no biologically-
targeted therapy. The interactions of BBCs with stromal cells are important determinants of tumor
biology, with inflammatory cells playing well-recognized roles in cancer progression. Despite the
fact that macrophage-BBC communication is bidirectional, important questions remain about how
BBCs affect adjacent immune cells. This study investigated monocyte-to-macrophage
differentiation and polarization, and gene expression in response to coculture with basal-like
versus luminal breast cancer cells. Changes induced by coculture were compared to changes
observed under classical differentiation and polarization conditions. Monocytes (THP-1 cells)
exposed to BBC cells in coculture had altered gene expression with upregulation of both M1 and
M2 macrophage markers. Two sets of M1 and M2 markers were selected from the PCR profiles
and used for dual immunofluorescence staining of BBC versus luminal cocultured THP-1s, and
cancer-adjacent, benign tissue sections from patients diagnosed with BBC or luminal breast cancer
confirming the differential expression patterns. Relative to luminal breast cancers, BBCs also
increased differentiation of monocytes to macrophages and stimulated macrophage migration.
Consistent with these changes in cellular phenotype, a distinct pattern of cytokine secretion was
evident in macrophage-BBC cocultures, including upregulation of NAP-2, Osteoprotegerin, MIG,
MCP-1, MCP-3 and IL-1β. Application of IL-1 receptor antagonist (IL-1RA) to cocultures
attenuated BBC-induced macrophage migration. These data contribute to an understanding of the
BBC-mediated activation of the stromal immune response, implicating specific cytokines that are
differentially expressed in basal-like microenvironments and suggesting plausible targets for
modulating immune responses to BBC.
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Basal-like breast cancer (BBC) is highly aggressive and disproportionately impacts young
African-American women (1, 2). Several studies suggest that breast cancer initiation and
progression is linked to inflammation [reviewed in (3)], and investigations have shown a
significant increase in the presence of innate and adaptive immune cells, including B cells, T
cells, eosinophils, and macrophages in malignant tissues (4–6). In particular, the presence of
macrophages or proliferating macrophages appears to be associated with BBC (4, 7). We
recently observed that BBC-stromal interactions may result in elevated expression of
cytokines, including cytokines that affect macrophage phenotype (8). To date, the signaling
pathways that modify the cross-talk between basal-like cells and immune cells in the
inflammatory microenvironment of BBCs remain uncertain, with gaps in understanding of
how BBCs alter the behavior and phenotype of macrophages.
Macrophages are white blood cells differentiated from monocytes, arising from progenitor
cells in the bone marrow (9). As monocytes migrate from peripheral blood into tissue, they
differentiate and are referred to as resident macrophages and primarily perform the
homeostatic function of debris clearance (10, 11). However, in response to damage-induced
inflammation, monocytes migrate into injured tissue where they differentiate and polarize to
phagocytize cellular debris, fight infection, and secrete compounds that promote wound
healing (10, 12, 13). Macrophages can also promote the development of tumors (14),
consistent with observations that wound healing and macrophage responses are correlated
with tumor progression (15–18). Tumor-associated macrophages, a subpopulation of M 2-
tropic macrophages (M2-macrophages), have been well-documented as the primary class of
macrophages in basal cell carcinoma, lung, melanoma, and thyroid cancers (14, 19–22).
They enhance tumor growth by stimulating angiogenesis and growth factor secretion (19,
22, 23), suppressing other immune responses (19, 24) or facilitating invasion and metastasis
(4, 21).
In light of the important role of macrophages in breast cancer progression, we performed
studies focused on the communication between macrophages and BBC. We evaluated
whether macrophages have unique interactions with BBCs compared to another, less
aggressive breast cancer subtype. Based on our previous findings suggesting elevated
cytokine expression due to basal-like interactions with stromal fibroblasts (7), we
hypothesized that BBCs recruit and polarize macrophages more effectively than luminal
breast cancers. Using the human, monocytic cell line THP-1 as a stable, established source
of monocytes, we evaluated the differentiation and polarization responses of monocytes to
BBC cells versus luminal breast cancer cells. Our results demonstrate that BBC cells
actively drive monocyte-to-macrophage differentiation and elucidate a novel IL-1β-




The BBC cell lines used in cocultures were HCC1937, MDA-MB-468, and SUM149.
Luminal breast cancer cell lines used included MCF-7, T47D and ZR-75-1. All cell lines
were purchased from ATCC and cultured in RPMI media (Gibco/Invitrogen) supplemented
with 10% FBS and penicillin/streptomycin. All ATCC cell lines undergo authentication tests
during the accessioning process, which is described in the online ATCC brochure
Maintaining High Standards in Cell Culture (www.atcc.org). THP-1 cells are an
immortalized human cell line cultured from the blood of a patient with acute monocytic
leukemia (25). After stringent characterization and validation by Tsuchiya et al., these cells
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were found to retain all the necessary markers and morphological features to be classified as
a monocytic cell population, able to undergo differentiation and polarization into functional,
mature macrophages (26). Thus, we have chosen to use them as our model system for ease
of handling and high reproducibility of results. THP-1 cells were maintained as a suspension
culture at a density of 800,000–1,000,000 cells/mL. Each cell line was individually
cocultured with THP-1 cells.
Differentiation of THP-1 monocytes to macrophages
To establish a positive control, THP-1 cells were differentiated and polarized according to
established protocols (20, 27), with minor modifications. Briefly, one million cells were
plated in 6-well plates in 3 mL RPMI media plus 25 ng/mL phorbol myristate acetate (PMA,
Sigma) for 48 hours of treatment to induce differentiation to macrophages. To polarize,
THP-1 macrophages were PMA treated for 48 hours, with addition of M1-polarizing
cytokines [20 ng/mL interferon-gamma (IFN-γ) and 100 ng/mL lipopolysaccharide (LPS)
(Prospec)] or M2-polarizing cytokines [20 ng/mL interleukin-4 (IL-4) and 20 ng/mL IL-13
(Prospec)] during the final 18 hours of treatment. This generated three macrophage
populations: PMA-differentiated macrophages, M1-polarized macrophages and M2-
polarized macrophages. Changes induced in cocultures were compared against these positive
controls. To coculture THP-1 cells with cancer cells, one million basal-like (HCC1937,
MDA-MB-468, and SUM149) or luminal (MCF7, T47D and ZR-75-1) breast cancer cell
lines were plated into 0.4 μM pore inserts of 6-well transwell plates in 2 mL of media, with
1mL of media added to the bottom of the well. After conditioning the media for 24 hours,
one million THP-1 cells were plated into the bottom wells of the transwell plates in 1 mL of
additional media. Cocultures were maintained for an additional 48 hours.
Analysis of THP-1 differentiation and polarization
To calculate the average % differentiation of THP-1 cells following cytokine treatment or
coculture, four replicates were plated with a set number of cells and after 48 hours the
suspended, unattached cells were counted. Differentiated/attached cells were calculated by
subtraction assuming no substantial increase in total cell number. Trypan blue was used to
evaluate cell viability for all cell counts. To complement these quantitative assessments of
percent differentiation, monocyte-to-macrophage differentiation and polarization was
confirmed based on characteristic morphological changes and phagocytic function.
Increased vacuolization and lysosomal compartmentalization, formation of migratory actin
cytoskeletal architecture (i.e. filopodia and lamellipodia), and fibroblast-like changes
indicative of polarization were observed and photographed (Fig. 1). Also, polystyrene
micro-particles (1μm size, Sigma) were diluted 1:1000, vortexed, and added to treatment
media at the end of the 48 hour treatment/coculture. The ability of the THP-1 cells to
phagocytize micro-particles was monitored on an Olympus IX-70 microscope by time-lapse
capture in two minute intervals at 40X magnification for 4 hours. Movies demonstrating
phagocytic function of THP-1 cells in response to coculture can be viewed in the
Supplemental material (Supplementary Movies_MCF-7 and _SUM149).
Immunofluorescent staining of differentiated and polarized THP-1 macrophages
Immunofluorescent imaging of cocultures was performed to evaluate classic protein markers
of M1 or M2 polarization. Prior to cell plating, 22×22–1.5 glass coverslips (Fisher) were
added to the bottom of the wells. Following treatment with chemicals or coculture, these
coverslips were fixed and stained for the expression of M1 macrophage markers NOS2a/
iNOS (C-11, Santa Cruz Biotechnology) and IL-7R (C-20, Santa Cruz Biotechnology), or
M2 macrophage markers CD36 (5–271, BioLegend, Inc.) and CD163 (RM3/1, BioLegend,
Inc.), according to standard protocols. Briefly, wells were rinsed with 1X PBS and fixed
with cold methanol (−10°C) for 10 minutes. After air drying, cells were washed three times
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with 1X PBS for 5 minutes, and incubated with 10% normal goat or mouse serum to block
for 20 minutes (depending on host antibody). After washing with 1X PBS for 5 minutes,
cells were incubated with primary antibody for 1 hour at a concentration of 5.0 μg/mL in
PBS plus 1.5% normal goat or mouse serum. Wells were washed three times with 1X PBS
for 5 minutes and incubated 45 minutes with Alexa-568 (IL-7R, red), Alexa-488 (CD36,
green), Alexa-405 (NOS2a, blue), and Alexa-647 (CD163, magenta) fluorochrome-
conjugated secondary antibodies (Molecular Probes) diluted to 2 μg/mL in PBS with 2%
normal goat or mouse serum in the dark. Coverslips were washed, removed from the wells
and mounted with glycerin for imaging on an Olympus BX-61 microscope at 20X
magnification.
RNA isolation and microarray gene expression profiling of control system-differentiated
THP-1 cells
RNA was isolated from THP-1 cells using the RNeasy kit (Qiagen). RNA purity and
integrity were confirmed by Agilent 2100 Bioanalyzer. THP-1 cells were run in triplicate
(three independent experiments) on 4×44K human whole genome microarray slides (Agilent
G4112F) according to the Agilent protocol (8). Cy3-labeled reference was Stratagene
Universal Human Reference spiked 1:1,000 with MCF-7 RNA and 1:1,000 with ME16C
RNA, and Cy-5 labeled cDNAs were from THP-1 total RNA. Labeled cDNAs were
hybridized to arrays overnight and washed before scanning on an Agilent G2505C
microarray scanner. All array data are available through the Gene Expression Omnibus.
Microarray data analyses
Only genes where more than 70% of microarrays had signal greater than 10 dpi in both
channels were included. Data were Lowess normalized and missing data was imputed using
k-nearest neighbors’ imputation (with k=10). Data were analyzed by multiclass SAM
(Significance Analysis of Microarrays) to identify genes that significantly changed by
treatment (4 classes: undifferentiated (monocytes), or PMA-differentiated, M1-polarized,
M2-polarized macrophages). Significant genes were evaluated for ontological enrichment
using Ingenuity Pathway Analysis (IPA), with Benjamini–Hochberg (B-H) multiple testing
correction for the two polarized classes. Significant functions and pathways were defined as
those with B-H p-values less than 0.05. Hierarchical clustering with 250 literature-defined
differentiation and polarization markers (Supplementary Table 2) was also performed to
evaluate concordance between the literature and the expression profiles of our THP-1
positive control (PMA-differentiated, M1- and M2-polarized) macrophages. A set of 43
markers (listed in Table 1) were selected based on concordance between literature and our
microarray data and a custom, quantitative RT-PCR array was developed for assaying
THP-1 mRNA expression changes in response to breast cancer coculture
microenvironments.
PCR array expression and analysis of THP-1 cells cocultured in BBC or luminal
microenvironments
Quantitative real-time PCR analysis was performed according to manufacturer’s protocol
(SA Biosciences) using an Applied Biosystems 7900HT Fast PCR machine. Relative
expression values from THP-1 cocultures were obtained by normalizing to GAPDH
expression and then normalizing to undifferentiated THP-1 monocytes. Hierarchical cluster
analysis was performed based on 38 of 43 markers that showed substantial variation across
the BBC and luminal cocultures. CD11c, F4/80, FN1, PTX3, TNF-α data were excluded
from further analyses due to low variation.
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Immunofluorescent staining of cancer-adjacent, normal tissues from BBC or luminal
breast cancer patients
Patient samples were obtained from the University of North Carolina, Lineberger
Comprehensive Cancer Center’s Tissue Procurement Facility, with informed consent and
under a School of Medicine Institutional Review Board-approved protocol. Histologically
normal-appearing sections adjacent to tumors were selected from patients diagnosed with
invasive primary tumors and classified as either the BBC or Luminal subtype of breast
cancer using the PAM50 algorithm (28) as applied to microarray data collected on adjacent
tumors (29). Neither of the patients with BBC had undergone neoadjuvant therapy prior to
tissue resection.
Immunofluorescent imaging of tissues adjacent to the tumor microenvironment was
performed to evaluate positive in vivo staining for the same M1 or M2 protein markers of
macrophage polarization used to evaluate BBC or luminal-cocultured THP-1 cells. Four
cancer-adjacent, benign tissue samples were selected based on the patients’ breast cancer
subtype (BBC or Luminal A). Paraffin sections 5μM thick were cut and H&E stained by the
UNC Histology Core. The additional sections were stained using standard protocols and the
same antibody reagents used for in vitro immunofluorescence staining (described above).
Cytokine protein array expression profiling of cocultured THP-1 macrophages
Cytokine protein expression of undiluted culture media was analyzed for 80 cytokines on the
Human Cytokine Antibody G Series 5 arrays (RayBiotech, Inc.) according to the
manufacturer’s protocol. Cell media (500 μl) was collected into clean tubes, centrifuged at
8000 rpm for 3 min to pellet cellular debris then transferred to clean tubes and stored at
−80°C. The glass chip was blocked and incubated overnight at 4°C with the experimental
samples. The next day, secondary biotin-conjugated and streptavidin antibody incubations
were performed, the slide was washed, air dried, and scanned on a GenePix 4000B scanner
at a wavelength of 532 nm using GenePix Pro 4.1 software. Expression for each cytokine
was first normalized to the internal control and fold-change was calculated by dividing the
normalized expression in coculture by the sum of the normalized expression of
corresponding monocultures (i.e. MCF7+THP-1 for MCF7:THP-1 cocultures). Cocultures
with a cytokine ratio of at least 1.50 were considered significantly upregulated and those
with a ratio less than or equal to 0.65 were significantly downregulated. Expression fold
change ratios between 1–1.49 and 0.66–0.99 are classified as non-significantly upregulated
and downregulated, respectively. Results are presented for the average of two biological
replicates per group (Table 2).
Migration assays of differentiated THP-1 macrophages
To evaluate the migratory capacity of macrophages under different conditions,
undifferentiated THP-1 cells were cultured in ultra-low attachment 6-well plates (Corning)
for 48 hours with PMA alone or with breast cancer cells. Breast cancer cell lines were not
suspension cultures; these cells were grown on inserts fitted to the 6-well low-attachment
plates. Breast cancer cells and THP-1 communication was via soluble factors secreted into
media. After brief trypsinization, loosely attached and suspended THP-1 cells were collected
and centrifuged at 2000 rpm for 5 minutes. THP-1 cells were resuspended in 1 mL of fresh
media, counted and 500,000 of coculture-treated cells were added to 8 μM migration inserts
in 1.5 mL of media, with 1 mL of media added to the bottom of the migration chambers.
Plates were incubated for 6 hours, then inserts were washed, fixed (10% neutral-buffered
formalin, 5 minutes) and stained with 0.2 % crystal violet in 1X PBS. Total number of
migrated cells were counted (4 fixed position fields/insert, 20X magnification) using
Volocity software on an Olympus IX-81 microscope. For IL-1RA blocking experiments,
500 ng/mL of IL-1RA (R&D Systems, Inc.) was added to THP-1 macrophages in the
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resuspension media before plating into migration inserts. The average number of migrated
cells was evaluated for THP-1 macrophages cocultured with MCF-7 and SUM149 cells,
with and without addition of IL-1RA.
RESULTS
Basal-like breast cancer cells drive differentiation of THP-1 cells
THP-1 cells were treated according to control conditions (PMA to differentiate into
macrophages and IFN-γ + LPS or IL-4 + IL-13 to polarize into M1 or M2 macrophages,
respectively). Phenotypes of the three populations of macrophages generated by control
treatment, including % differentiation, morphological characteristics and immunofluorescent
staining of polarization markers, appear in Fig. 1A, B and C, respectively. These populations
served as positive controls for comparison of THP-1 macrophage responses to coculture
differentiation and polarization. The phenotype of THP-1 cells differed when cocultured
with luminal (MCF-7, T47D, ZR-75-1) cells versus BBC (HCC1937, MDA-MB-468,
SUM149) cell lines. After 48 hours in coculture, BBCs caused greater differentiation of
THP-1 cells into macrophages. BBC cell lines induced approximately 56% differentiation,
while luminal cells only produced 28% differentiation (two-tailed t-test p-value = 0.011, Fig.
2A). Similar to morphologic changes in positive control cells (Fig. 1B), morphological
changes were observed in cocultured THP-1 macrophages, but were more distinct in BBC
cocultures, with representative pictures of SUM149 (basal-like) and MCF-7 (luminal) cells
shown in Fig. 2B. SUM149 cocultured THP-1 macrophages are primarily attached, have
increased vacuole formation and show characteristics of polarization via cytoskeletal
rearrangement, whereas MCF-7 cocultured THP-1 cells still largely resemble
undifferentiated cells, though with some increased vacuolization compared to
undifferentiated THP-1 monocytes. Both BBC- and luminal-cocultured THP-1 populations
demonstrated the ability to phagocytize latex micro-particles (Supplementary Movie files).
Gene expression data from cocultured cells mirrored phenotypic changes. Two of the genes
assayed were predominantly monocytic markers, CCR2 and CX3CR1 (30). Although THP-1
cells cocultured with all three luminal cell lines increased differentiation as measured by
elevated expression of CD68, a macrophage marker, the populations continued to express
monocytic markers, indicating the persistence of larger numbers of monocytes in these
cocultures (Fig. 2C). These cells may represent an “inflammatory monocyte” phenotype,
with high expression of CCR2 and low expression of CX3CR1 (31). This class of
monocytes is involved in triggering the immune response and in our coculture data appears
to be more abundant in response to luminal cancers. Conversely, THP-1 cells exposed to
BBC cells downregulate both CCR2 and CX3CR1, suggesting differentiation to more
mature macrophages.
Basal-like breast cancer cells drive polarization of THP-1 cells
Because macrophages show plasticity that cannot be captured with a small number of
markers, it was important to establish hallmark changes in THP-1 cells across a wide range
of genes. It was also important to establish that the reproducible system based on an
established cell line (THP-1 cells) reflected M1/M2 changes for primary peripheral blood
mononuclear cells that more closely represent resident macrophages. Unsupervised
hierarchical clustering of microarray data from PMA and M1- or M2-polarized THP-1 cells
revealed reproducible patterns of gene expression (Supplementary Fig. 1A) with expected
canonical pathway alterations in response to control conditions (Supplementary Tables 1 and
2). In addition, an extensive review of the literature identified 250 genes indicative of
monocyte-to-macrophage differentiation and polarization (Supplementary Table 3). The list
of genes was primarily derived from mouse models or investigations using peripheral blood
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monocytes. Of the 250 genes, 209 (84%) were similarly expressed in THP-1 cells
(Supplementary Fig. 1B), demonstrating the usefulness of the optimized THP-1 control
system to adequately define the monocyte-to-macrophage differentiation and polarization
processes. Using markers that characterize the M1 and M2 polarization states of
macrophages (Table 1), we found that relative to luminal breast cancers, basal-like breast
cancers induce more widespread phenotypic changes associated with both M1 and M2
macrophage polarization. All three basal-like lines strongly induced THP-1 cells to
differentiate and polarize, with the most robust response in SUM149 cells (Fig. 2C), a cell
line isolated from inflammatory breast cancer (32), whereas several more of the polarization
markers are downregulated in response to MCF-7, T47D or ZR-75-1 luminal breast cancer
cells.
Given that BBCs showed increases in both M1 and M2 markers, we evaluated whether this
mixed phenotype was due to a dual population of THP-1 cells (i.e. some M1 and some M2
polarized cells) or whether this was evidence of phenotypic plasticity using
immunofluorescence. Two sets of M1- and M2-predominant markers were used. In Fig. 2D,
both dual positive cells [staining for IL-7R (M1) and CD36 (M2) or iNOS (M1) and CD163
(M2)] and singly positive cells (exclusively expressing either M1 or M2 markers) are shown
(33–36). This was similar to the positive controls (Fig. 1D), where a mixed population of
M1- and M2-polarized macrophages was also observed. The percentages of positively
stained THP-1 cells for CD36, IL-7R, iNOS and CD163 following each culture condition
were 3, 0, 0, and 0% for UND, respectively; 39, 87, 62, and 21% for PMA, respectively; 45,
81, 89, and 54% for IFN-γ plus LPS, respectively; and 66, 34, 80 and 40% for IL-4 plus
IL-13 treatment, respectively. This phenotypic duality, even in the presence of specific
polarization stimuli, has been observed previously with macrophages (37, 38). Consistent
with the q-RT-PCR data, the presence of a dual-stained macrophage population was more
frequent in THP-1 cells cocultured with basal-like SUM149 cells compared to luminal
MCF-7 cells; where the percentages of positively stained THP-1 cells for CD36, IL-7R,
iNOS and CD163 were 23, 100, 83, and 29% with MCF-7 cocultured cells, respectively; and
69, 92, 95, and 32% with SUM149 cocultured THP-1 cells, respectively.
Cancer-adjacent tissue sections from patients with BBC or luminal breast cancer also
express differential patterns of macrophage polarization markers
To determine whether the phenotypic patterns observed in THP-1 cocultures were also
present within the stromal microenvironments of patients, we used the same M1 and M2
polarization marker pairs (CD36, IL-7R and CD163, iNOS) to dual-stain sections of
histologically normal tissues adjacent to tumors. Figure 3A shows the H&E-stained sections
for two BBC and two luminal cancer-adjacent tissues, along with the merged images of dual
staining for CD36 (M2, green) and IL-7R (M1, red). Dual M1/M2 staining is more
pronounced in the basal-adjacent tissues compared to the luminal-adjacent sections. A
similar pattern of expression is observed with the CD163 (M2, red) and iNOS (M1, blue)
stained tissues (Fig. 3B). Both staining pairs demonstrate there are more M2-positive
macrophages in the basal-adjacent normal tissues (CD36-green and CD163-red) and more
M1-postive macrophages in the luminal-adjacent normal tissues (IL-7R-red and iNOS-blue).
Additionally, there are more dual-staining or mixed-phenotype macrophages in the basal-
adjacent stromal compartments compared to the luminal (Fig. 3A-yellow and Fig. 3B-
magenta), confirming the PCR expression profiles and recapitulating the in vitro patterns of
macrophage expression in vivo.
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THP-1 cells express differential cytokine profiles in response to basal-like versus luminal
coculturing
To identify the soluble cytokines that mediate the communication between BBCs and
macrophages, we assayed expression of 80 cytokines using protein antibody arrays.
THP-1:MCF-7 coculture resulted in 2 significantly upregulated (≥ 1.5 fold increase in
expression) and 13 significantly downregulated (≤ 0.65 fold expressed) cytokines. In
contrast, THP-1:SUM149 cocultures significantly upregulated and downregulated 9 or 20
cytokines, respectively (Table 2). The most highly upregulated cytokine in SUM149:THP-1
cocultures was a potent neutrophil chemoattractant NAP-2/CXCL7 (upregulated nearly 8-
fold), but MCP-1, Osteoprotegerin, IL-1β, MCP-3, LIF, Ostoepontin, MIG, and IL-5 were
also upregulated by at least 50%. Interestingly, G-CSF was significantly downregulated in
MCF-7:THP-1 cocultures but not in SUM149:THP-1 cocultures.
THP-1 cells become more migratory in response to BBC cells in an IL-1 dependent
mechanism
Our previous results (8) found that IL-1β was altered in BBC cocultures with fibroblasts, so
we were intrigued to observe that this cytokine was also upregulated at RNA and protein
levels in BBC:THP-1 cocultures (Fig. 2C (RNA) and Table 2). To evaluate the role of IL-1β
in BBC-stromal interactions, the antagonist, IL-1RA was used to block coculture-induced
IL-1 signaling. Migratory function was significantly higher in macrophages that were
cocultured with BBC cells (two-tailed t-test, p-value=0.039, Fig. 4A) and especially for
SUM149-cocultured THP-1 macrophages. Addition of 500 ng of IL-1RA during the 6 hour
migration assay dramatically diminished this BBC-induced THP-1 migration (Fig. 4B), but
had no significant impact in MCF-7:THP-1 cocultures.
DISCUSSION
The presence of intratumoral macrophages is associated with tumor progression (19) and
with BBC subtype of breast cancer (7). Intravital imaging has demonstrated directly that
macrophages intravasate mammary tumors during progression (39). In addition, low grade
inflammation without overt clinical consequences, or ‘smoldering inflammation’ (40), has
been implicated in cancer etiology. Consistent with this, we and others have recently
observed that obese women at a higher risk for BBC and obese cancer patients have a higher
prevalence of macrophages in breast adipose tissue (41, 42). Together these results suggest
that both etiology and progression of BBCs may be affected by communication with
macrophages.
Paracrine loops involving macrophages and breast cancer cells have previously emphasized
the role of CSF-1 (39, 43). A CSF-1 signature has also been found in ductal carcinoma in
situ (DCIS) (18) and has been shown to predict invasive breast cancer aggressiveness (16).
Similarly, inflammatory monocytes with high CCL2 expression play an important role in
breast cancer progression (44). Collectively, studies on macrophage-cancer cell interactions
have emphasized the diversity of macrophages (19). As explained by Suzuki et al. (45),
macrophages have complex transcriptomes designed to control a diversity of gene products
for specialized tasks in a temporally and spatially defined manner. We were interested in
understanding how BBCs interact with macrophages (similar to our work in fibroblasts (8)),
but recognized that a means of characterizing the complex and dynamic changes in
macrophages was important. In the current study, we have established and validated a panel
of markers that can be used to identify subtypes of macrophages in cancer cell cocultures.
Our findings document that relative to luminal breast cancers, BBCs induce a distinct
subpopulation of macrophages both in vitro and in vivo. In vitro, BBCs induced more
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macrophage differentiation, polarization and migration. Several other coculture systems,
including cocultures with endothelial cells (46), adipocytes (47) and mesenchymal stem
cells (48) have reported increases in cytokine levels when BBCs interact with stroma. In the
case of macrophage-BBC interactions, it appears that the soluble interactions promote a
population with features of both types. Mantovani and colleagues have suggested that
macrophages in tumors are more similar to alternatively activated M2 macrophages (rather
than activated M1 macrophages) (40), with gene profiling experiments on TAMs supporting
these findings (49). However, tumor-associated-macrophages have tended not to adhere to
these binary definitions (40) and instead often have similarities to both M1 and M2
macrophages, with particular similarities to macrophages present during development (e.g.
increased Wnt signaling) (19, 21). Our in vivo findings in a limited number of patient
specimens are concordant with our in vitro findings, showing more M1/M2 dual-stained
macrophages in basal-like cases than in luminal cases. Future studies should validate our in
vitro findings in larger tumor datasets, and should focus on identifying the cytokines that
mediate the macrophage behavior in response to BBCs.
Among the cytokines differentially expressed in BBC-macrophage cocultures was IL-1β,
which was upregulated by approximately 90%. Using IL-1RA to block the activity of IL-1β,
we restricted the macrophage migration to levels observed in luminal cocultures. A previous
report has documented increases in IL-1β upregulation in THP-1 cocultures with one basal-
like cell line, HCC1937 (50), and demonstrated that IL-1β expression is upstream of COX-2
expression in the cancer cells. Our results extend the observations regarding IL-1β
expression from a single cancer cell line to the class of basal-like cell lines and document a
phenotypic effect of IL-1RA on macrophages. Furthermore, our results regarding basal-like
specificity of the stroma-mediated IL-1β expression may help explain elevated COX-2 in
BBCs (51) and in basal-like-stromal interactions (8). Further mechanistic details remain
unresolved, but these results suggest that IL-1β may be an important regulator of BBC-
stroma interactions. Previous studies have suggested an association between IL-1β
expression and progression (52) and genetic variation in IL-1β has been linked with breast
cancer survival (53). Likewise, IL-1RA is induced in some mesenchymal stem/stromal cell
types (54) as a means of controlling inflammation. If fibroblasts and endothelial cells in the
vicinity of the cancer mitigate the effects of IL-1β through upregulation of the decoy
receptor, unraveling the role of this cytokine in breast cancer progression will necessitate
future studies with intact glands that include several different cell types.
We concluded that BBCs induce distinct macrophage populations. Binary classification of
macrophage phenotypes is problematic in our study, due to dual staining of macrophages for
both M1 and M2 markers. However this challenge in classifying macrophages based on
single markers is consistent with previous literature. For example, Qian and colleagues
defined TNF-α as M1-specific (19), in agreement with Mantovani et al., who described
TNF-α as upregulated in M1-macrophages and downregulated in M2-macrophages (55).
However, Zeyda et al. demonstrated TNF-α expression in both M1- and M2-polarized
macrophages (56). Similarly, we originally defined CD163 as an M1 marker based on the
work by Fuentes et al. and Qian et al., (19, 57) but ultimately reassigned it to an M2 pattern
of expression based on recently published studies (58–60) and our own experimental results
with M2-polarizing cytokines. Such discrepancies in “hallmark biomarkers” of macrophage
differentiation or polarization make interpretation of polarization markers challenging. Use
of a positive control system for polarizing THP-1 cells facilitated our assignment of markers
toward M1 or M2 predominance (and therefore represents a database of potential utility to
other investigators); but our observation that even chemically polarized macrophages exhibit
both M1 and M2 phenotypes simultaneously is a cautionary tale against interpreting
macrophage expression based on positivity for only one class of markers.
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In summary, by using multiple markers to assay macrophage polarization phenotypes and by
evaluating differentiation with multiple cell-based assays, our results document distinct
macrophage behavior in response to BBCs. While BBCs induced in vitro differentiation and
migration of macrophages via an IL-1β-dependent mechanism, the migration was repressed
in the presence of an IL-1β inhibitor. Given the importance of macrophages in the BBC
microenvironment and in BBC-progression, novel in vitro systems for studying the
reciprocal communication between BBCs and macrophages are important and could lead to
newly identified targets. As pointed out by Ojalvo et al. (21), targeting the macrophages may
be more effective than targeting genetically altered, chemotherapy-resistant cancer cells.
Future in vivo preclinical studies or epidemiologic studies evaluating this pathway may help
to identify novel strategies for targeting aggressive BBCs.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. THP-1 phenotypes in response to classical stimuli
THP-1 cells were differentiated and/or polarized with classically-defined stimuli [PMA for
differentiation into macrophage and M1-trophic (IFN-γ and LPS) or M2-trophic (IL-4 and
IL-13) cytokines for polarization]. (A) THP-1 cells differentiated (78–83%) in treated
compared to undifferentiated (UND) conditions (5%), and (B) treated cells undergo
characteristic morphological changes, including attachment, increased vacuolization,
fibroblast-like changes, and in the M1- or M2-treated cells, formation of lamellipodia and
filopodia at their ends. (C) Treated cells were immune-positive for M1-predominant (IL-7R
(red), iNOS (blue)) and M2-predominant (CD36 (green), CD163 (magenta)) proteins, with
two sets of markers documenting subpopulations of macrophages that are dual positive
(yellow) for M1 and M2 markers.
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Figure 2. Basal-like coculture drives THP-1 differentiation and polarization
(A) BBC cells significantly differentiated (p-value=0.011) THP-1 cells into macrophages,
with percentage differentiation roughly twice that of luminal cells. (B) Morphological
differentiation of THP-1 cells is greater after coculture with SUM149 (basal-like) cells
compared to MCF-7 (luminal) cells. (C) Similarly, BBC coculturing results in stronger
overall q-RT-PCR expression of M1 and M2 markers and decreases in monocytic markers
(CCR2 and CX3CR1), while THP-1s cocultured with luminal breast cancer cell lines
continue to strongly express monocytic markers. (D) MCF-7 and SUM149 cocultured
THP-1 cells were dual-stained for iNOS (blue, M1) and CD163 (magenta, M2) or IL-7R
(red, M1) and CD36 (green, M2) using immunofluorescence, suggesting a mixed pattern of
M1 and M2-polarized macrophage expression, especially in response to SUM149 cells.
THP-1 phagocytic function to engulf latex micro-particles following coculture was also
evaluated and time-lapse movies can be viewed in the Supplementary materials.
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Figure 3. Cancer-adjacent normal tissues express a similar in vivo pattern of macrophage
polarization distinguishing BBC from luminal breast cancer
(A) H&E stained sections for tissues adjacent to BBC or luminal breast cancer and dual
stained immunofluorescent images with staining for M1/IL-7R (red) and M2/CD36 (green).
(B) H&E sections for the same specimens, but with dual staining for M1/iNOS (blue) and
M2/CD163 (red). More dual stained M1/M2 macrophages and higher numbers of M2
positive macrophages are observed in the BBC-adjacent tissues in this set of samples.
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Figure 4. THP-1 migration responses to BBC coculture are reduced by treatment with IL-1RA
(A) THP-1 cells cocultured with BBCs (HCC1937, MDA-MB-468, SUM149) have
significantly greater migratory ability (p-value=0.039) than THP-1s cocultured with luminal
cells (MCF-7, T47D, ZR-75-1). The bar chart represents the average of three independent
experiments across all three luminal lines or BBC cell lines. (B) THP-1 migration induced
by SUM149 coculture is attenuated by treatment with IL-1RA. THP-1 migration levels in
BBC cocultures that result after blocking IL-1 receptors are similar to those observed
following luminal coculturing.
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Table 1
Gene targets and controls used to assess macrophage phenotype by RT-PCR.
Gene Symbol Gene Name, Entrez Gene ID Higher in Mo/M1/M2
CD11b Itgam, Integrin, alpha M, 3684 M2
CD11c Itgax, Integrin, alpha X, 3687 M1
CD36 Leukocyte differentiation antigen, 948 M2
CD68 CD68 molecule, 968 M1 & M2
CD163 CD163 molecule, 9332 M2
CD206 Mannose receptor C type 1, MRC1, 4360 M2
CCL19 Chemokine ligand 19, MIP-3b, 6363 M1
CCL20 Chemokine ligand 20, MIP-3a, 20297 M1
CCR2 Chemokine receptor 2, CD192, MCP-1R, 729230 Mo
CCR7 Chemokine receptor 7, CD197, 1236 M1
CXCL1 Chemokine (C-X-C motif) ligand 1, NAP-3, 2919 M1
CXCL3 Chemokine (C-X-C motif) ligand 3, MIP-2b, 2921 M1
CX3CR1 Chemokine (C-X3-C motif) receptor 1, 1524 Mo
IL-1b Interleukin 1, beta; IL1F2, 3553 M1
IL-6 Interleukin 6 (interferon, beta 2), 3569 M1
IL-7R Interleukin 7 receptor, CD127, IL7RA, 3575 M1
IL-8 Interleukin 8, CXCL8, NAP1, 3576 M1
IL-12 Interleukin 12A, p35, 3592 M1
IL-23 Interleukin 23, alpha, 51561 M1
Arg 1 Arginase, liver, 383 M2
BCL2A1 BCL2-related protein A1, 597 M1
COX2 Prostaglandin-endoperoxide synthase 2, PTGS2, 5743 M1
BIRC3 Baculoviral IAP repeat-containing 3, 330 M1
CSF-1 Colony stimulating factor 1 (MF), M-CSF, 1435 M2
CSF-2 Colony stimulating factor 2 (granulocyte-macrophage), GM-CSF,1437 M1
EDN1 Endothelin 1,1906 M1
F4/80 Zinc finger protein 808, EMR1, 2015 M1 & M2
FGL2 Fibrinogen-like 2, fibroleukin,10875 M2
FN1 Fibronectin 1,2335 M2
HS3ST1 Heparan sulfate (glucosamine) 3-O-sulfotransferase 1, 9957 M1
HSD11B1 Hydroxysteroid (11-beta) dehydrogenase 1, 3290 M2
INDO Indoleamine 2,3-dioxygenase 1, IDO1, 3620 M1
iNOS Nitric oxide synthase 2, inducible; NOS2A, 4843 M1
LIPA Lipase A, lysosomal acid, cholesterol esterase, 3988 M2
MAF v-Maf musculoaponeurotic fibrosarcoma oncogene homolog, 4094 M2
MMP14 Matrix metallopeptidase 14, 4323 M2
MS4A4A Membrane-spanning 4-domains, subfamily A-member 4, 51338 M2
MSR1 Macrophage scavenger receptor 1, CD204, 4481 M2
OASL 2′-5′-oligoadenylate synthetase-like, 8638 M1
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Gene Symbol Gene Name, Entrez Gene ID Higher in Mo/M1/M2
OPN Osteopontin; SPP1, Secreted phosphoprotein 1, 6696 M1
PTX3 Pentraxin 3, long; TNFAIP5, 5806 M1
TNF-a Tumor necrosis factor (superfamily member 2), 7124 M1
VEGF-a Vascular endothelial growth factor A, 7422 M2
GAPDH Gyceraldehyde-3-phosphate dehydrogenase, 2597 N/A
WWP1 Ubiquitin, protein ligase 1, 11059 N/A
HGDC Human Genomic DNA Contamination N/A
RTC Reverse Transcription Control N/A
PPC Positive PCR Control N/A
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